359 related articles for article (PubMed ID: 27516441)
1. Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
Weinhold N; Ashby C; Rasche L; Chavan SS; Stein C; Stephens OW; Tytarenko R; Bauer MA; Meissner T; Deshpande S; Patel PH; Buzder T; Molnar G; Peterson EA; van Rhee F; Zangari M; Thanendrarajan S; Schinke C; Tian E; Epstein J; Barlogie B; Davies FE; Heuck CJ; Walker BA; Morgan GJ
Blood; 2016 Sep; 128(13):1735-44. PubMed ID: 27516441
[TBL] [Abstract][Full Text] [Related]
2. Hierarchy of mono- and biallelic
Munawar U; Rasche L; Müller N; Vogt C; Da-Via M; Haertle L; Arampatzi P; Dietrich S; Roth M; Garitano-Trojaola A; Steinhardt MJ; Strifler S; Gallardo M; Martinez-Lopez J; Bargou RC; Heckel T; Einsele H; Stühmer T; Kortüm KM; Barrio S
Blood; 2019 Sep; 134(10):836-840. PubMed ID: 31340981
[No Abstract] [Full Text] [Related]
3. Multiple myeloma clonal evolution in homogeneously treated patients.
Corre J; Cleynen A; Robiou du Pont S; Buisson L; Bolli N; Attal M; Munshi N; Avet-Loiseau H
Leukemia; 2018 Dec; 32(12):2636-2647. PubMed ID: 29895955
[TBL] [Abstract][Full Text] [Related]
4. Genome instability in multiple myeloma.
Neuse CJ; Lomas OC; Schliemann C; Shen YJ; Manier S; Bustoros M; Ghobrial IM
Leukemia; 2020 Nov; 34(11):2887-2897. PubMed ID: 32651540
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse.
Krzeminski P; Corchete LA; García JL; López-Corral L; Fermiñán E; García EM; Martín AA; Hernández-Rivas JM; García-Sanz R; San Miguel JF; Gutiérrez NC
Oncotarget; 2016 Dec; 7(49):80664-80679. PubMed ID: 27811368
[TBL] [Abstract][Full Text] [Related]
6. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
Gralewski JH; Post GR; van Rhee F; Yuan Y
Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.
Bolli N; Avet-Loiseau H; Wedge DC; Van Loo P; Alexandrov LB; Martincorena I; Dawson KJ; Iorio F; Nik-Zainal S; Bignell GR; Hinton JW; Li Y; Tubio JM; McLaren S; O' Meara S; Butler AP; Teague JW; Mudie L; Anderson E; Rashid N; Tai YT; Shammas MA; Sperling AS; Fulciniti M; Richardson PG; Parmigiani G; Magrangeas F; Minvielle S; Moreau P; Attal M; Facon T; Futreal PA; Anderson KC; Campbell PJ; Munshi NC
Nat Commun; 2014; 5():2997. PubMed ID: 24429703
[TBL] [Abstract][Full Text] [Related]
8. Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.
Rasche L; Chavan SS; Stephens OW; Patel PH; Tytarenko R; Ashby C; Bauer M; Stein C; Deshpande S; Wardell C; Buzder T; Molnar G; Zangari M; van Rhee F; Thanendrarajan S; Schinke C; Epstein J; Davies FE; Walker BA; Meissner T; Barlogie B; Morgan GJ; Weinhold N
Nat Commun; 2017 Aug; 8(1):268. PubMed ID: 28814763
[TBL] [Abstract][Full Text] [Related]
9. Prognosis, Biology, and Targeting of
Flynt E; Bisht K; Sridharan V; Ortiz M; Towfic F; Thakurta A
Cells; 2020 Jan; 9(2):. PubMed ID: 31991614
[TBL] [Abstract][Full Text] [Related]
10. Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages.
Yang M; Topaloglu U; Petty WJ; Pagni M; Foley KL; Grant SC; Robinson M; Bitting RL; Thomas A; Alistar AT; Desnoyers RJ; Goodman M; Albright C; Porosnicu M; Vatca M; Qasem SA; DeYoung B; Kytola V; Nykter M; Chen K; Levine EA; Staren ED; D'Agostino RB; Petro RM; Blackstock W; Powell BL; Abraham E; Pasche B; Zhang W
J Hematol Oncol; 2017 May; 10(1):100. PubMed ID: 28472989
[TBL] [Abstract][Full Text] [Related]
11. Accelerated single cell seeding in relapsed multiple myeloma.
Landau HJ; Yellapantula V; Diamond BT; Rustad EH; Maclachlan KH; Gundem G; Medina-Martinez J; Ossa JA; Levine MF; Zhou Y; Kappagantula R; Baez P; Attiyeh M; Makohon-Moore A; Zhang L; Boyle EM; Ashby C; Blaney P; Patel M; Zhang Y; Dogan A; Chung DJ; Giralt S; Lahoud OB; Peled JU; Scordo M; Shah G; Hassoun H; Korde NS; Lesokhin AM; Lu S; Mailankody S; Shah U; Smith E; Hultcrantz ML; Ulaner GA; van Rhee F; Morgan GJ; Landgren O; Papaemmanuil E; Iacobuzio-Donahue C; Maura F
Nat Commun; 2020 Jul; 11(1):3617. PubMed ID: 32680998
[TBL] [Abstract][Full Text] [Related]
12. Disease progression in patients with multiple myeloma is associated with a concurrent alteration in the expression of both oncogenes and tumour suppressor genes and can be monitored by the oncoprotein phenotype.
Pope B; Brown R; Luo XF; Gibson J; Joshua D
Leuk Lymphoma; 1997 May; 25(5-6):545-54. PubMed ID: 9250826
[TBL] [Abstract][Full Text] [Related]
13. Clonal competition with alternating dominance in multiple myeloma.
Keats JJ; Chesi M; Egan JB; Garbitt VM; Palmer SE; Braggio E; Van Wier S; Blackburn PR; Baker AS; Dispenzieri A; Kumar S; Rajkumar SV; Carpten JD; Barrett M; Fonseca R; Stewart AK; Bergsagel PL
Blood; 2012 Aug; 120(5):1067-76. PubMed ID: 22498740
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in ANRIL is associated with relapse in patients with multiple myeloma after autologous stem cell transplant.
Poi MJ; Li J; Sborov DW; VanGundy Z; Cho YK; Lamprecht M; Pichiorri F; Phelps MA; Hofmeister CC
Mol Carcinog; 2017 Jul; 56(7):1722-1732. PubMed ID: 28150872
[TBL] [Abstract][Full Text] [Related]
15. The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.
Boyle EM; Deshpande S; Tytarenko R; Ashby C; Wang Y; Bauer MA; Johnson SK; Wardell CP; Thanendrarajan S; Zangari M; Facon T; Dumontet C; Barlogie B; Arbini A; Rustad EH; Maura F; Landgren O; Zhan F; van Rhee F; Schinke C; Davies FE; Morgan GJ; Walker BA
Nat Commun; 2021 Jan; 12(1):293. PubMed ID: 33436579
[TBL] [Abstract][Full Text] [Related]
16. Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.
Walker BA; Boyle EM; Wardell CP; Murison A; Begum DB; Dahir NM; Proszek PZ; Johnson DC; Kaiser MF; Melchor L; Aronson LI; Scales M; Pawlyn C; Mirabella F; Jones JR; Brioli A; Mikulasova A; Cairns DA; Gregory WM; Quartilho A; Drayson MT; Russell N; Cook G; Jackson GH; Leleu X; Davies FE; Morgan GJ
J Clin Oncol; 2015 Nov; 33(33):3911-20. PubMed ID: 26282654
[TBL] [Abstract][Full Text] [Related]
17. From astrocytoma to glioblastoma: a clonal evolution study.
Yang F; Zou Y; Gong Q; Chen J; Li WD; Huang Q
FEBS Open Bio; 2020 May; 10(5):744-751. PubMed ID: 32069381
[TBL] [Abstract][Full Text] [Related]
18. The clonal evolution during long-term clinical course of multiple myeloma.
Mishima Y; Mishima Y; Shirouchi Y; Nishimura N; Yokoyama M; Okabe T; Inoue N; Uryu H; Fukuta T; Hatake K; Terui Y
Int J Hematol; 2021 Feb; 113(2):279-284. PubMed ID: 32864713
[TBL] [Abstract][Full Text] [Related]
19. Genomic complexity of multiple myeloma and its clinical implications.
Manier S; Salem KZ; Park J; Landau DA; Getz G; Ghobrial IM
Nat Rev Clin Oncol; 2017 Feb; 14(2):100-113. PubMed ID: 27531699
[TBL] [Abstract][Full Text] [Related]
20. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.
Egan JB; Shi CX; Tembe W; Christoforides A; Kurdoglu A; Sinari S; Middha S; Asmann Y; Schmidt J; Braggio E; Keats JJ; Fonseca R; Bergsagel PL; Craig DW; Carpten JD; Stewart AK
Blood; 2012 Aug; 120(5):1060-6. PubMed ID: 22529291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]